NK-128 inhibited the proliferation of leukemia cells in a concentration-dependent manner (Figure 2A); BV173 and SUP-B15 cells tended to be more sensitive than K562, MYL, and MYL-R (an imatinib-resistant subline of MYL). The gene discussed is PML; the disease is leukemia.